These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2257873)

  • 1. Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers.
    van den Berg G; van Steveninck F; Gubbens-Stibbe JM; Schoemaker HC; de Boer AG; Cohen AF
    Eur J Clin Pharmacol; 1990; 39(3):315-6. PubMed ID: 2257873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.
    Feliciano NR; Bouvet AA; Redalieu E; Castellana J; Luders RC; Schwartz DJ; Shum L; Zak S; Arnold JD; Leese PT
    Am Heart J; 1990 Aug; 120(2):483-9. PubMed ID: 2382633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of food on the absorption of metoprolol administered as an Oros drug delivery system to man.
    Lecaillon JB; Massias P; Schoeller JP; Abadie F
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):245S-249S. PubMed ID: 4005130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations.
    Richard J; Cardot JM; Godbillon J
    Eur J Drug Metab Pharmacokinet; 1994; 19(4):375-80. PubMed ID: 7737240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steady-state bioavailability and day-to-day variability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing.
    Sandberg A; Abrahamsson B; Svenheden A; Olofsson B; Bergstrand R
    Pharm Res; 1993 Jan; 10(1):28-34. PubMed ID: 8430057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of site of drug delivery on the systemic availability of metoprolol: comparison of intragastric infusion and 14/190 Oros administration.
    Warrington SJ; Barclay SP; John VA; Shotton PA; Wardle HM; Good W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):219S-224S. PubMed ID: 4005126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of impaired renal function on the pharmacokinetics of metoprolol after single administration of a 14/190 metoprolol OROS system.
    Lloyd P; John VA; Signy M; Smith SE
    Am Heart J; 1990 Aug; 120(2):478-82. PubMed ID: 2382632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
    Warrington SJ; Barclay SP; John VA; Shotton PA; Good W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugs.
    Yu LX; Straughn AB; Faustino PJ; Yang Y; Parekh A; Ciavarella AB; Asafu-Adjaye E; Mehta MU; Conner DP; Lesko LJ; Hussain AS
    Mol Pharm; 2004; 1(5):357-62. PubMed ID: 16026005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the bioavailability of propranolol and metoprolol by food.
    Melander A; Danielson K; Scherstén B; Wåhlin E
    Clin Pharmacol Ther; 1977 Jul; 22(1):108-12. PubMed ID: 872491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
    Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG
    J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary effects of long-term beta 2-blockade in healthy subjects: comparative study of metoprolol OROS.
    Bauer K; Rakusan S; Kaik G
    Am Heart J; 1990 Aug; 120(2):473-7. PubMed ID: 1974382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.
    Godbillon J; Gerardin A; Richard J; Leroy D; Moppert J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):213S-218S. PubMed ID: 4005125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food.
    Sathyan G; Xu E; Thipphawong J; Gupta SK
    BMC Clin Pharmacol; 2007 Feb; 7():2. PubMed ID: 17270055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of sustained-release tablets of metoprolol in Chinese.
    Diao Y; Li L
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):232-4. PubMed ID: 8237398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations.
    Gesquiere I; Darwich AS; Van der Schueren B; de Hoon J; Lannoo M; Matthys C; Rostami A; Foulon V; Augustijns P
    Br J Clin Pharmacol; 2015 Nov; 80(5):1021-30. PubMed ID: 25917170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of pharmacokinetics after oral administration of slow-release metoprolol tablets and pharmacogenetic considerations.
    Shimizu H; Noguchi H; Uno K
    Arzneimittelforschung; 1992 Jun; 42(6):802-6. PubMed ID: 1418033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of food intake on the bioavailability of urapidil in healthy volunteers.
    Kirsten R; Nelson K; Molz KH; Gielsdorf W; Haerlin R
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):298-301. PubMed ID: 2737799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.